The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 20, 2018
Filed:
Dec. 03, 2015
Applicants:
Centre Nationale DE Recherche Scientifique, Paris, FR;
Institut Curie, Paris, FR;
Universite DE Montpellier, Montpellier, FR;
Inventors:
Jamal Tazi, Clapiers, FR;
David Grierson, Vancouver, CA;
Florence Mahuteau-Betzer, Saint-Remy-les-Chevreuse, FR;
Pierre Roux, Saint Gely du Fesc, FR;
Assignees:
CENTRE NATIONALE DE RECHERCHE SCIENTIFIQUE, Paris, FR;
INSTITUT CURIE, Paris, FR;
UNIVERSITE DE MONTPELLIER, Montpellier, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/166 (2006.01); A61K 31/417 (2006.01); A61K 31/4406 (2006.01); A61K 31/4409 (2006.01); A61K 31/4192 (2006.01); A61K 31/4439 (2006.01); A61K 31/4725 (2006.01);
U.S. Cl.
CPC ...
A61K 31/166 (2013.01); A61K 31/417 (2013.01); A61K 31/4192 (2013.01); A61K 31/4406 (2013.01); A61K 31/4409 (2013.01); A61K 31/4439 (2013.01); A61K 31/4725 (2013.01);
Abstract
A method of treating a disease selected from the group consisting of cancer, Duchenne muscular dystrophy, AIDS, and progeria, that includes administering to a patient in need thereof an effective quantity of at least one compound of formula (IV) or a pharmaceutically acceptable salt thereof.